Fasenra
PHONETIC PRONUNCIATION: Fasenra
Description
Fasenra: Uses, Dosage, Demographic, Side Effects, Interactions, and Generic Options Fasenra is a prescription medication used for the treatment of severe eosinophilic asthma (SEA) in patients aged 12 years and above. This drug is manufactured by AstraZeneca and is administered through subcutaneous injections. In this article, we will delve into Fasenra’s uses, dosage, demographic, side effects, interactions, and generic options. Uses Fasenra is primarily used for the treatment of severe eosinophilic asthma (SEA) in patients aged 12 years and older. This condition is characterized by a high level of eosinophils, a type of white blood cell, in the blood, which can contribute to inflammation in the airways. SEA does not always respond to standard asthma medications, such as corticosteroids and bronchodilators, and Fasenra is designed to inhibit eosinophil growth to reduce the severity of these asthma symptoms. Dosage The dosage of Fasenra is determined by a patient's body weight. The recommended dosage is 30mg every 4 weeks, administered using a subcutaneous injection in the upper arm, thigh, or abdomen. The medication should be administered by a healthcare professional initially, and patients may later self-administer with proper instructions from their doctor. Demographic Fasenra is approved for use in patients aged 12 years and older with severe eosinophilic asthma. It is essential to note that the medication has not been studied in patients with other forms of asthma or in patients younger than 12 years. Therefore, the drug must be used with caution in these patients as there is limited data available. Side Effects Like other medications, Fasenra has potential side effects that may occur during its use. Common side effects include headache, injection site reactions, and fever/chills. If any of these symptoms are severe or persist over an extended period, patients should contact their doctor immediately. Other side effects that may be less common include throat irritation, rash, and swelling of the face, lips, or tongue. In very rare cases, Fasenra can cause life-threatening allergic reactions. Interactions Fasenra has no known interactions with other medications. However, it is essential to disclose any other medications or supplements a patient may be taking before starting Fasenra treatment. Some medicines, such as corticosteroids, may impact the effectiveness of Fasenra and should only be used under strict medical supervision. Generic Options Currently, there are no generic versions of Fasenra available on the market. As with any medication, patients should discuss generic options with their doctor to determine the most appropriate treatment course. Conclusion Fasenra is a prescription medication used for the treatment of severe eosinophilic asthma in patients aged 12 years and above. The medication is administered through subcutaneous injections and is highly effective in reducing asthma symptoms. While the drug has some potential side effects and rare risks, it is an effective treatment option for many asthma sufferers. If you think that Fasenra might be right for you, make sure to discuss it with your doctor to determine if the medication is appropriate for your needs.
Faq for Fasenra
Fasenra is used as an add-on maintenance treatment for severe eosinophilic asthma in patients aged 12 years and older. It helps to reduce the frequency of asthma attacks and improve lung function.
Fasenra is a monoclonal antibody that specifically targets and inhibits the actions of interleukin-5 (IL-5), a protein produced by immune cells called eosinophils. By reducing the number of eosinophils in the blood and lungs, Fasenra helps to prevent inflammation and swelling of the airways, thus reducing asthma symptoms.
The most common side effects reported with Fasenra include headaches, injection site reactions (such as pain, itching, and redness), sore throat, and cold-like symptoms (nasopharyngitis). It is important to discuss any side effects with your healthcare provider.
No, Fasenra is not a steroid. It belongs to a class of medications called monoclonal antibodies, which specifically target certain proteins involved in the immune system response. Steroids, on the other hand, work by reducing inflammation in a broad manner.
Fasenra is administered through subcutaneous injection (under the skin) once every 4 weeks for the first 3 doses, and then once every 8 weeks thereafter. It is recommended to receive the injection in a healthcare facility initially to ensure proper administration technique, but it may also be self-administered at home if you are adequately trained.
Yes, Fasenra is commonly used as an add-on therapy along with other asthma medications, including controller medications like inhaled corticosteroids or long-acting beta-agonists. It is important to follow your healthcare provider's recommendations and not discontinue any other prescribed medications without consulting them.
The effects of Fasenra may vary from person to person. Some individuals may experience improvement in asthma symptoms within a few weeks of starting treatment, while others may take longer to see the full benefits. It is crucial to continue using Fasenra regularly as prescribed by your healthcare provider to achieve the best results.